EVGEN PHARMA
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. Evgen’s pipeline is based on our proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Our objective is to use our Sulforadex® technology to turn this scientific promise into commercially successful products.
EVGEN PHARMA
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2007-01-01
Address:
Wilmslow, Cheshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.evgen.com
Total Employee:
1+
Status:
Active
Contact:
+44 151 705 3532
Email Addresses:
[email protected]
Total Funding:
16.36 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Acceleris Capital
Acceleris Capital investment in Venture Round - Evgen Pharma
Seneca Partners
Seneca Partners investment in Venture Round - Evgen Pharma
The North West Fund
The North West Fund investment in Venture Round - Evgen Pharma
Sarum Partners
Sarum Partners investment in Venture Round - Evgen Pharma
Enterprise Ventures
Enterprise Ventures investment in Venture Round - Evgen Pharma
The North West Fund
The North West Fund investment in Series A - Evgen Pharma
Rising Stars Growth Fund
Rising Stars Growth Fund investment in Series A - Evgen Pharma
Imprimatur Capital
Imprimatur Capital investment in Seed Round - Evgen Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-03-22 | Evgen Pharma names chief business officer |
Official Site Inspections
http://www.evgen.com Semrush global rank: 5.42 M Semrush visits lastest month: 1.56 K
- Host name: pl1.jpcinet.co.uk
- IP address: 212.113.198.195
- Location: Crawley United Kingdom
- Latitude: 51.1149
- Longitude: -0.1841
- Timezone: Europe/London
- Postal: RH11
More informations about "Evgen Pharma"
TheraCryf | A clinical stage therapeutics company
Formerly Evgen Pharma plc, the Company acquired Chronos Therapeutics in April 2024. TheraCryf, the new name for the Group, reflects a wider mission and broader portfolio. The …See details»
Evgen Pharma - LinkedIn
Evgen Pharma | 920 followers on LinkedIn. Evgen Pharma is a clinical stage drug development company focused on cancer and neurological disease. Our pipeline is based on our …See details»
Evgen Pharma - Craft
Jun 25, 2024 Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. Evgen’s pipeline is based on our proprietary …See details»
CHAIRMAN’S STCHAIRMAN’S STAAATEMENTTEMENT - evgen.com
Evgen Pharma plc Annual Report & Accounts 2020 OF SULFORAPHANE CLINICAL POTENTIAL REALISING THE Registered in England and Wales Domiciled in the United Kingdom …See details»
Corporate Summary - Evgen
SFX-01 in HR+ HER 2- Breast Cancer Breast cancer -genetically and clinically heterogeneous disease with multiple subtypes. HR+ HER2- subtype is the most common of all the breast …See details»
Evgen Pharma plc_2023 AR_WEB - theracryf.com
02 Evgen Pharma plc 2023 Annual Report & Financial Statements OVERVIEW EVGEN PHARMA AT A GLANCE WHO WE ARE We are a clinical-stage, UK-based, global leader in the ® …See details»
Evgen Pharma - Funding, Financials, Valuation & Investors
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. Search Crunchbase. Start Free Trial . ... How much funding has …See details»
Evgen - VentureRadar
Merseyside based company, Evgen, is developing Sulforadex®, a patented pharmaceutical composition with enormous potential in the prevention and treatment of prostate cancer and …See details»
Company Evgen Pharma plc London S.E. - MarketScreener.com
Oct 20, 2015 Theracryf PLC, formerly Evgen Pharma plc, is a clinical-stage therapeutics company. The Company is engaged in developing a new generation of therapeutics in …See details»
Evgen Pharma plc Half year Report - theracryf.com
Evgen is a clinical stage drug development company focused on the development of sulforaphane-based compounds, a new class of pharmaceuticals which are synthesised in a …See details»
Evgen Pharma – Acquisition, Fundraising and Change of Name
Mar 20, 2024 Evgen Pharma plc (AIM: EVG), the clinical stage drug development company developing sulforaphane-based medicines for the treatment of multiple diseases, announces …See details»
Evgen Company Profile Funding & Investors | YourStory
Evgen Pharma is a clinical stage drug development company focused on cancer and neurological disease. Their pipeline is based on their proprietary Sulforadex® technology, and includes a …See details»
Evgen Pharma, University of Michigan to study colorectal cancer …
Jun 14, 2022 Evgen Pharma CEO Dr Huw Jones said: “This new project is our fifteenth pre-clinical collaboration to date. Colorectal cancer is a relatively common disease and a cancer …See details»
SFX-01 positive update in bowel cancer models
Feb 27, 2024 Dr Huw Jones, CEO of Evgen Pharma said: "These early data from our collaborators in the USA show encouraging evidence of activity of SFX-01 in another …See details»
Evgen Pharma plc Half year Report - Theracryf
Evgen Pharma is a clinical stage drug development company developing sulforaphane based medicines for the treatment of multiple diseases. The Company's core technology is …See details»
Evgen Pharma (EVG) Share Price, News & Analysis - MarketBeat
Apr 25, 2024 Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory …See details»
Juvenescence Announces Licensing Agreement with Evgen …
Sep 15, 2020 About Evgen Pharma plc Evgen Pharma is a clinical stage drug development company developing sulforaphane based medicines for the treatment of multiple diseases.See details»
Evogene Ltd. (EVGN) Stock Price, Quote & News - Stock ... - Stock …
2 days ago About EVGN. Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life …See details»
Evogen Company Profile - Office Locations, Competitors, Revenue …
Evogen $4.89 m in total funding,. See insights on Evogen including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»